Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Cannabidiol for the treatment of positive and negative symptoms in schizophrenia spectrum disorders: a systematic review and meta-analysis

Eur Arch Psychiatry Clin Neurosci. 2026 Apr 28. doi: 10.1007/s00406-026-02249-3. Online ahead of print.

NO ABSTRACT

PMID:42047775 | DOI:10.1007/s00406-026-02249-3

Document this CPD

AI-Assisted Evidence Search

Share Evidence Blueprint

QR Code

Search Google Scholar

Save as PDF

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review